On July 15th, the FDA issued a warning that Cipro (and other drugs) should not be prescribed for urinary tract infections unless there are no other options.
The FDA’s new “black box” warnings apply to fluoroquinolone antibiotics, a class that includes Johnson & Johnson’s Levaquin, Bayer drug Cipro, Merck & Co.’s Avelox and other brands, as well as generics.
The class of meds already carries a boxed warning that the drugs increase the risk of tendonitis and tendon rupture–added to the label in 2008–and cautionary language about the risk of serious nerve damage.
Read more here.
Leave A Comment